Prognostic Factors in Dedifferentiated Chondrosarcoma: A Retrospective Analysis of a Large Series Treated at a Single Institution.
Ruoyu MiaoEdwin ChoyKevin A RaskinJoseph H SchwabGunnlaugur Petur NielsenVikram DeshpandeIvan A ChebibThomas F DeLaneyFrancis J HornicekGregory M CoteYen-Lin E ChenPublished in: Sarcoma (2019)
The prognosis of DDCS is poor. Complete resection remains a significant prognostic factor for local control. Chemotherapy with doxorubicin and cisplatin seems to have better PFS. More prognostic, multicenter trials are warranted to further explore the effectiveness of chemotherapy in selected DDCS patients.